Early changes in tumor size in patients treated for advanced stage nonsmall cell lung cancer do not correlate with survival

Cancer

Volumn 116, Issue 6, 2010, Pages 1615-

  Oxnard, Geoffrey R ^a   Schwartz, Lawrence H ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; FOLLOW UP; HUMAN; LETTER; LUNG NON SMALL CELL CANCER; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR VOLUME;

CARCINOMA, NON-SMALL-CELL LUNG; DISEASE PROGRESSION; HUMANS; LUNG NEOPLASMS; PROGNOSIS; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 77949383746     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24803     Document Type: Letter

References (4)

1. Birchard KR, Hoang JK, Herndon JE Jr, Patz EF Jr. Early changes in tumor size in patients treated for advanced stage nonsmall cell lung cancer do not correlated with survival. Cancer. 2009;115:581-586.
2. Campbell ME, Mandrekar SJ, Hillman SL, et al. What is the added value of actual tumor measurements (TM) in predicting overall survival (OS)? The North Central Cancer Treatment Group (NCCTG) find*ings [abstract]. J Clin Oncol. 2008;26(May 20 suppl). Abstract 6520.
3. Schwartz LH, Mazumdar M, Brown W, Smith A, Panicek DM. Variability in response assessment in solid tumors: effect of number of lesions chosen for measurement. Clin Cancer Res. 2003;9:4318-23.
4. Hillman SL, Sargent DJ, An M-W, et al. Evaluation of RECIST criteria in determining the response to treatment in solid tumors: A North Central Cancer Treatment Group (NCCTG) investigation [abstract]. Proc Am Soc Clin Oncol. 2003;22. Abstract 2095.